Compared to Estimates, Clarivate (CLVT) Q2 Earnings: A Look at Key Metrics

Core Insights - Clarivate PLC (CLVT) reported revenue of $650.3 million for the quarter ended June 2024, reflecting a year-over-year decline of 2.8% and an EPS of $0.20, down from $0.21 a year ago [1] - The revenue fell short of the Zacks Consensus Estimate of $653.29 million by 0.46%, while the EPS exceeded the consensus estimate of $0.18 by 11.11% [1] Revenue Breakdown - Intellectual Property revenues were $201.60 million, surpassing the average estimate of $199.95 million, but showing a year-over-year decline of 6.8% [3] - Life Sciences & Healthcare revenues totaled $104.20 million, below the average estimate of $107.80 million, marking a year-over-year decrease of 5.7% [4] - Academia & Government revenues reached $344.50 million, exceeding the average estimate of $336.67 million, with a slight year-over-year increase of 0.7% [5] - Transactional and other revenues amounted to $136.10 million, surpassing the average estimate of $120.74 million, but reflecting a year-over-year decline of 10.3% [6] - Re-occurring revenues were reported at $108.60 million, below the average estimate of $111.58 million, indicating a year-over-year decrease of 2.2% [7] - Subscription revenues were $405.60 million, falling short of the average estimate of $420.73 million, with a minimal year-over-year change of -0.1% [8] Stock Performance - Clarivate's shares have returned +9.6% over the past month, contrasting with the Zacks S&P 500 composite's decline of -6.7% [8] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [8]